Crystalline form of CXCR2 antagonist and application thereof
Grant
US12577235B2
Kind: B2
Mar 17, 2026
Assignee
SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY CO., LTD
Inventors
Feng Gao, Yuan Chen, Peng Zhang, Yunfu Luo
Abstract
A crystalline form of CXCR2 antagonist, such as Compound 1, is used in preparing a drug for treating CXCR2-related diseases.
CPC Classifications
C07D 405/12
C07B 2200/13
C07C 57/145
C07C 233/83
A61P 11/00
Filing Date
2020-07-10
Application No.
17597563
Claims
5